Another Victory for Immune Checkpoint Blockade in Melanoma: Adjuvant Ipilimumab Over Interferon.

Betof Warner, Allison

Another Victory for Immune Checkpoint Blockade in Melanoma: Adjuvant Ipilimumab Over Interferon. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology 02 2020 - 529-531 p. digital

Publication Type: Editorial; Comment

1527-7755

10.1200/JCO.19.02988 doi


Humans
Interferon alpha-2
Ipilimumab
Melanoma
Nivolumab
United States